Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
US Army
Johnson and Johnson

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020675

« Back to Dashboard

NDA 020675 describes URSO FORTE, which is a drug marketed by Forest Labs Inc and is included in one NDA. It is available from three suppliers. Additional details are available on the URSO FORTE profile page.

The generic ingredient in URSO FORTE is ursodiol. There are seven drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ursodiol profile page.
Summary for 020675
Tradename:URSO FORTE
Applicant:Forest Labs Inc
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020675
Ingredient-typeBile Acids and Salts
Suppliers and Packaging for NDA: 020675
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
URSO 250 ursodiol TABLET;ORAL 020675 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0591-2998 0591-2998-01 100 TABLET in 1 BOTTLE (0591-2998-01)
URSO 250 ursodiol TABLET;ORAL 020675 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0591-3005 0591-3005-01 100 TABLET in 1 BOTTLE (0591-3005-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Dec 10, 1997TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Jul 21, 2004TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.